Literature DB >> 23273963

Public reporting of healthcare-associated infection data in Europe. What are the views of infection prevention opinion leaders?

M Martin1, W Zingg, S Hansen, P Gastmeier, A W Wu, D Pittet, M Dettenkofer.   

Abstract

BACKGROUND: There is increasing interest in public reporting of healthcare-associated infection (HAI) data in Europe, mostly for patient safety reasons. But it is uncertain whether patients and other stakeholders benefit from them. AIM: To obtain the views of European infection control opinion leaders and provide information about public reporting of HAI in Europe.
METHODS: European Centre for Disease Prevention and Control HAI surveillance National Contact Points and other opinion leaders in infection control from 34 European countries were invited to complete questionnaires about HAI reporting in their countries and to provide their personal views about public reporting. The issue was discussed during two discussion rounds in 2010 and 2012.
FINDINGS: Response rates were 100% and 93.9% for the two surveys. Current practices on publishing HAI data vary widely across Europe. Many experts support the idea of publishing HAI data. All representatives from the seven countries with established public reporting were in favour of such practice. After the first discussion round, 12 experts changed their opinion. Finally, the majority of the experts acknowledged the positive influence on hospitals by increasing competition on the basis of quality, but they are hesitant about publishing infection rates as these can be misinterpreted by patients and need standardization and validation.
CONCLUSION: Opinion leaders in infection control in Europe acknowledged the positive influence of public reporting on hospital performance and resulting efforts to reduce infections. They were in favour of reporting of individual hospital data if (i) process indicators rather than outcome data are reported, and (ii) delivery of surveillance is monitored by external audits.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23273963     DOI: 10.1016/j.jhin.2012.10.010

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  6 in total

1.  Impact of laws aimed at healthcare-associated infection reduction: a qualitative study.

Authors:  Patricia W Stone; Monika Pogorzelska-Maziarz; Julie Reagan; Jacqueline A Merrill; Brad Sperber; Catherine Cairns; Matthew Penn; Tara Ramanathan; Elizabeth Mothershed; Elizabeth Skillen
Journal:  BMJ Qual Saf       Date:  2015-06-04       Impact factor: 7.035

2.  Risk of surgical site infection in older patients in a cohort survey: targets for quality improvement in antibiotic prophylaxis.

Authors:  Antonella Agodi; Annalisa Quattrocchi; Martina Barchitta; Veronica Adornetto; Aldo Cocuzza; Rosalia Latino; Giovanni Li Destri; Antonio Di Cataldo
Journal:  Int Surg       Date:  2015-03

3.  Introduction of software tools for epidemiological surveillance in infection control in Colombia.

Authors:  Cristhian Hernández-Gómez; Gabriel Motoa; Marta Vallejo; Víctor M Blanco; Adriana Correa; Elsa de la Cadena; María Virginia Villegas
Journal:  Colomb Med (Cali)       Date:  2015-06-30

4.  Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections.

Authors:  Tjallie van der Kooi; Hugo Sax; Didier Pittet; Jaap van Dissel; Birgit van Benthem; Bernhard Walder; Vanessa Cartier; Lauren Clack; Sabine de Greeff; Martin Wolkewitz; Stefanie Hieke; Hendriek Boshuizen; Jan van de Kassteele; Annemie Van den Abeele; Teck Wee Boo; Magda Diab-Elschahawi; Uga Dumpis; Camelia Ghita; Susan FitzGerald; Tatjana Lejko; Kris Leleu; Mercedes Palomar Martinez; Olga Paniara; Márta Patyi; Paweł Schab; Annibale Raglio; Emese Szilágyi; Mirosław Ziętkiewicz; Albert W Wu; Hajo Grundmann; Walter Zingg
Journal:  Intensive Care Med       Date:  2017-12-16       Impact factor: 17.440

5.  Key priorities in the prevention and control of healthcare-associated infection: a survey of European and other international infection prevention experts.

Authors:  Markus Dettenkofer; Hilary Humphreys; Henri Saenz; Jean Carlet; Håkan Hanberger; Christian Ruef; Andreas Widmer; Martin Wolkewitz; Barry Cookson
Journal:  Infection       Date:  2016-05-25       Impact factor: 3.553

6.  Impact of availability of guidelines and active surveillance in reducing the incidence of ventilator-associated pneumonia in Europe and worldwide.

Authors:  Klaus Kaier; Marie-Laurence Lambert; Uwe K Frank; Werner Vach; Martin Wolkewitz; Evelina Tacconelli; Jordi Rello; Ursula Theuretzbacher; Maria Martin
Journal:  BMC Infect Dis       Date:  2014-04-12       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.